Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Royaume-Uni (3)
Advocacy (policy advocacy, lobbying)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Other (4)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Preclinical